Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplastic Cells, Circulating × Denosumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Giant Cell Tumor of Bone 1 Carcinoma, Renal Cell 1

Interventions

Blood Specimen Collection 2 Denosumab 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03070002 2018-11-20

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Northwestern University

Phase 2 Terminated

1 enrolled 6 charts

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡